← Back to headlines
Guggenheim Cuts Price Target for Valneva SE
Guggenheim has lowered its price target for Valneva SE (VALN) from $13 to $11. This adjustment reflects a revised financial outlook for the European biotechnology company.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
WHO Declares End of Ebola Outbreak in Uganda Amid Rising Cases in Congo
1h ago
FDA Approves Breakthrough Pancreatic Cancer Pill That Nearly Doubles Survival Rates
1h ago
Busy Philipps Reveals Rare Brain Tumor Diagnosis and Recovery
2h ago
Nutritionists Explain How Dietary Fiber Can Improve Sleep Quality
7h ago